Genetic study to better assess kids’ unusual skin spots
Part of Cancer clinical trials.
This Phase 1 study looks at genetic risk factors in children with unusual skin lesions. The goal is to help doctors better decide which spots should be closely watched or safely biopsied.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 20 years old or younger.
- You (and your parent/guardian) can sign consent, and you can give assent if asked.
- Have one or more unusual (atypical) skin lesions that your care plan includes monitoring and/or biopsy or removal within the next 6 months.
- The lesion to be evaluated should not be on the palms, soles, or inside body linings (mucous areas), and it should be in an area where hair can be trimmed.
- The spot should not be actively bleeding, ulcerated (open sore), already biopsied, scarred, or a known melanoma spot.
- The area to be biopsied should not have active psoriasis, eczema, or another skin condition that could interfere with sampling.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device that uses a special light to image skin lesions after applying an FDA-approved cream. It aims to see if the device can help doctors see benign skin growths more clearly before they are removed.
This study looks at skin spots that might be unusual moles or early melanoma using a special microscope that sees deep into the skin. It aims to match these microscope images with genetic information to better understand these spots.
This study looks at the DNA and other biology from skin lesions (like melanoma or unusual pigmented moles) in children and teens. It aims to better understand what these tumors are and how they behave, using tissue samples collected during routine care.
This study looks at people and families with a high risk of melanoma, especially if it runs in the family or is linked to certain genetic conditions. The goal is to better understand what causes melanoma and how to detect it earlier.
This study looks at why some people develop melanocytic nevi (common skin moles) by examining genetic factors. It may help researchers understand the causes of moles and could guide future skin health research.
This study is testing a handheld device that scans skin lesions to help detect melanoma. If you have a spot that your doctor thinks could be melanoma, this study will see how well the device works compared to standard checks.
Hear when a new Skin Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.